Filing Details
- Accession Number:
- 0000899243-19-028345
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-02 16:10:36
- Reporting Period:
- 2019-11-27
- Accepted Time:
- 2019-12-02 16:10:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1552451 | Myokardia Inc | MYOK | Pharmaceutical Preparations (2834) | 455500552 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654909 | Jake Bauer | C/O Myokardia Inc. 333 Allerton Avenue South San Francisco CA 94080 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-11-27 | 13,096 | $65.13 | 53,134 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-29 | 7,336 | $65.52 | 45,798 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-29 | 800 | $66.32 | 44,998 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person.
- Represents the weighted average sale price of the shares sold ranging from $65.00 to $65.44 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price of the shares sold ranging from $65.00 to $65.99 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price of the shares sold ranging from $66.04 to $66.44 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
